A startup that spun out of research at the University of Maryland School of Medicine was acquired 18 months after forming.
In a deal announced this week, Living Pharma was acquired by Lentigen Technology Inc., a Gaithersburg-based subsidiary of Miltenyi Biotec GmbH. Terms were not disclosed.
{iframe}https://technical.ly/baltimore/2017/07/21/living-pharma-acquisition/?utm_campaign=Baltimore%20Editorial%20Email&utm_source=hs_email&utm_medium=email&utm_content=54505268&_hsenc=p2ANqtz-_q__b6v5dvVMMH5k-HybKsXg2P45u-5JgDxYXPaygRimZa5wNyWmKhPZwSzjdU7rhvD_mcIX2IITkabFwo8JiC-1Nbzg&_hsmi=54505268{/iframe}